| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Clarus Lifesciences III, L.P. | 10%+ Owner | $123M | May 12, 2021 | ||
| Nicole Sweeny | Chief Commercial Officer | $973K | Feb 12, 2023 | ||
| Jill DeSimone | Director | $365K | Jun 5, 2024 | ||
| Marcio Souza | Chief Executive Officer, Director | $246K | Jul 29, 2024 | ||
| Timothy Edwin Kelly | Chief Financial Officer | $150K | Jul 29, 2024 | ||
| Alex Nemiroff | General Counsel and Secretary | $136K | Jul 29, 2024 | ||
| Lauren Mastrocola | Principal Accounting Officer | $79.5K | Jul 29, 2024 | ||
| Gregory Norden | Director | Jun 5, 2024 | |||
| Stefan Vitorovic | Director | May 26, 2022 | |||
| William D. Young | Director | Jun 5, 2024 | |||
| Bernard Ravina | Chief Medical Officer | Jun 22, 2022 | |||
| Dean J. Mitchell | Director | Jun 5, 2024 | |||
| BSOF Parallel Master Fund L.P. | 10%+ Owner | Oct 6, 2021 | |||
| Merit Ester Cudkowicz | Director | Jun 5, 2024 | |||
| Jeffrey Chodakewitz | Director | Jun 5, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|